Book ; Online ; E-Book: Blood and marrow transplantation long term management
survivorship after transplant
2021
Abstract: Hematopoietic cell transplantation (HCT) provides curative therapy for a variety of diseases. Over the past several decades, significant advances have been made in the field of HCT and now HCT has become an integral part of treatment modality for a ... ...
| Author's details | edited by Bipin N Savani, Andre Tichelli |
|---|---|
| Abstract | "Hematopoietic cell transplantation (HCT) provides curative therapy for a variety of diseases. Over the past several decades, significant advances have been made in the field of HCT and now HCT has become an integral part of treatment modality for a variety of hematologic malignancies and some nonmalignant diseases. HCT remains an important treatment option for a wide variety of hematologic and nonhematologic disorders, despite recent advances in the field of immunologic therapies. Factors driving this growth include expanded disease indications, greater donor options (expanding unrelated donor registries and haploidentical HCT), and accommodation of older and less fit recipients. The development of less toxic pretransplant conditioning regimens, more effective prophylaxis of graft-versus-host disease (GVHD), improved infection control, and other advances in transplant technology have resulted in a rapidly growing number of transplant recipients surviving long-term free of the disease for which they were transplanted. The changes over decades in the transplant recipient population and in the practice of HCT will have almost inevitably altered the composition of the long-term survivor population over time. Apart from an increasingly older transplant recipient cohort, the pattern of transplant indications has shifted from the 1990s when chronic myeloid leukemia made up a significant proportion of allo-HCT indications. Changes in cell source, donor types, conditioning regimens, GVHD prophylaxis, and supportive care have all occurred, with ongoing reductions in both relapse and non-relapse mortality (NRM) have been demonstrated"-- |
| Keywords | Bone marrow/Transplantation ; Hematopoietic stem cells/Transplantation ; Surgery ; Medical |
| Subject code | 617.44 |
| Language | English |
| Size | 1 online resource (467 pages) |
| Edition | Second edition. |
| Publisher | Wiley-Blackwell |
| Publishing place | Hoboken, New Jersey |
| Document type | Book ; Online ; E-Book |
| Remark | Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer |
| ISBN | 1-119-61273-X ; 1-119-61278-0 ; 1-119-61274-8 ; 1-119-61269-1 ; 978-1-119-61273-5 ; 978-1-119-61278-0 ; 978-1-119-61274-2 ; 978-1-119-61269-8 |
| Database | ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture |
Full text online
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.